The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II neoadjuvant (N-) gemcitabine (G) and pembrolizumab (P) for locally advanced urothelial cancer (laUC): Interim results from the cisplatin (C)-ineligible cohort of GU14-188.
 
Hristos Z. Kaimakliotis
No Relationships to Disclose
 
Nabil Adra
Research Funding - Genentech (Inst); Merck (Inst)
 
William Kevin Kelly
Honoraria - Bayer; Janssen Oncology
Consulting or Advisory Role - Merck Sharp & Dohme
Research Funding - Amgen (Inst); Bayer (Inst); BioClin Therapeutics (Inst); Endocyte (Inst); Exelixis (Inst); Janssen Oncology (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst); Sarah Cannon Research Institute (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Merck Sharp & Dohme
 
Edouard John Trabulsi
Consulting or Advisory Role - GenomeDx
Speakers' Bureau - Astellas Medivation; Janssen; Johnson & Johnson; Pfizer
 
Richard C. Lauer
Travel, Accommodations, Expenses - Mirati Therapeutics
 
Joel Picus
Consulting or Advisory Role - Novo Nordisk; Sanofi
Research Funding - Agensys (Inst); BioClin Therapeutics (Inst); BioClin Therapeutics (Inst); eFFECTOR Therapeutics (Inst); Endocyte (Inst); Innocrin Pharma (Inst); Mirati Therapeutics (Inst); Rexahn Pharmaceuticals (Inst); Seagen (Inst); TRACON Pharma (Inst)
 
Zachary L Smith
Consulting or Advisory Role - Photocure
 
Radhika Walling
No Relationships to Disclose
 
Timothy A. Masterson
No Relationships to Disclose
 
Adam C Calaway
No Relationships to Disclose
 
Michael O. Koch
No Relationships to Disclose
 
Elizabeth Sonderman
No Relationships to Disclose
 
Pingfu Fu
No Relationships to Disclose
 
Gordon Goolamier
No Relationships to Disclose
 
Cheryl Eitman
No Relationships to Disclose
 
Lee Evan Ponsky
No Relationships to Disclose
 
Christopher J. Hoimes
Honoraria - Seagen
Consulting or Advisory Role - 2bPrecise; Bristol-Myers Squibb; Eisai; Foundation Medicine; Genentech/Roche; Merck Sharp & Dohme; Prometheus; Seagen
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Genentech/Roche; Seagen
Research Funding - Merck Sharp & Dohme; Merck Sharp & Dohme (Inst)
(OPTIONAL) Uncompensated Relationships - 2bPrecise (Inst)